A widely cited study about the use of Hydroxychloroquine and azithromycin to treat COVID-19, published in March 2020, has been retracted by its publisher, Elsevier. The study, published in Elsevier’s International Journal of Antimicrobial Agents, was retracted in the January 2025 edition of the journal (issued last month). “Concerns have been raised regarding this article, […] Continue reading ->
Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading ->
Climate change, unplanned urbanization, sprawling cities, and the El Nino effect all converged to make 2024 a “historic” year for dengue transmission. With increased opportunities for Aedes aegypti mosquitoes–the insects that carry dengue– to breed, cases reached a record 12.7 million cases in the WHO’s Americas Region, nearly three times more than in 2023. This translates […] Continue reading ->